apl-1202
Showing 1 - 2 of 2
Non-muscle Invasive Bladder Cancer Trial in Shanghai (APL-1202, Epirubicin Hydrochloride)
Recruiting
- Non-muscle Invasive Bladder Cancer
- APL-1202
- Epirubicin Hydrochloride
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 21, 2022
Non-Muscle Invasive Bladder Cancer (NMIBC) Trial in New York, Myrtle Beach (APL-1202)
Completed
- Non-Muscle Invasive Bladder Cancer (NMIBC)
- APL-1202
-
New York, New York
- +1 more
Jul 16, 2020